Features
New Insights on Management of Central Serous Chorioretinopathy
Updates to classification, imaging technology, and data on pathophysiology guide treatment.
By Gideon Nkrumah, MD, Supriya Arora, MD, Jay Chhablani, MD
Dexamethasone Intracameral Drug-delivery Suspension for Inflammation Following Vitreoretinal Surgery
Treatment of postoperative inflammation with this suspension may offer significant clinical benefits to retinal surgeons and their patients.
By Daniel F. Kiernan, MD, FACS
Simplifying Sutureless Scleral-fixated Intraocular Lens Surgery
Incorporate these techniques for enhanced efficiency and efficacy.
By Christina Y. Weng, MD, MBA
An Approach to Surgical Complications in Retina
Consider challenges that may arise before, during, and after retinal surgery.
By Jacob S. Duker, MD, Caroline R. Baumal, MD
Combined Anterior-Posterior Surgery With Malignant Melanoma
Part 1 of a 4-part roundtable series on difficult surgical cases.
By Peter K. Kaiser, MD, Timothy G. Murray, MD, MBA, FACS, Christina Y. Weng, MD, MBA, et al.
Vitreoretinal Practice Patterns in the COVID-19 Era
Studies have examined whether changes to practice have affected patients' vision.
By Matthew R. Starr, MD, David Xu, MD, AJAY E. KURIYAN, MD, MS
Departments
UPFRONT: Repercussions of Reduced Surgery During COVID
By Peter K. Kaiser, MD
CODING Q&A: The Lowdown on Compounded Medications
Customization and lower costs help give these medications an essential role in patient care.
By Suzanne L. Corcoran, COE
NEW PRODUCT APPLICATIONS: New Technology in the Omega 600 Indirect Ophthalmoscope
Visionboost enhances the view with vitreous opacities.
By Karen Appold, contributing writer
News
SUBSPECIALTY NEWS: Geographic atrophy trials, gene therapy, funding for trials, and more.
By Jerry Helzner, contributing editor